Preliminary Results of an Ongoing Prospective Clinical Trial on the Use of 68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Staging of High-Risk Prostate Cancer Patients.
Mapelli P, Ghezzo S, Samanes Gajate AM, Preza E, Brembilla G, Cucchiara V, Ahmed N, Bezzi C, Presotto L, Bettinardi V, Savi A, Magnani P, Menichini R, Coliva A, Neri I, Di Gaeta E, Gianolli L, Freschi M, Briganti A, De Cobelli F, Scifo P, Picchio M.
Mapelli P, et al. Among authors: samanes gajate am.
Diagnostics (Basel). 2021 Nov 9;11(11):2068. doi: 10.3390/diagnostics11112068.
Diagnostics (Basel). 2021.
PMID: 34829417
Free PMC article.